Publications by authors named "Robin Steigerwald"

Claim this Profile
A
A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
Lisa Henning, Kathrin Endt, Robin Steigerwald, Michael Anderson, Ariane Volkmann

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
Robin Steigerwald, David A Brake, José Barrera, Christopher J Schutta, Markus Kalla

Vaccine· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
Wei-Gang Hu, Robin Steigerwald, Marcus Kalla, Ariane Volkmann, David Noll

Vaccine· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, Ariane Rodriguez, Robin Steigerwald

PLoS One· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, Ariane Rodriguez, Robin Steigerwald

PLoS One· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Marc Schweneker, Andrea S Laimbacher, Gert Zimmer, Susanne Wagner, Elisabeth M Schraner, Robin Steigerwald

J Virol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-γ Primes Keratinocytes for HSV-1-Induced Inflammasome Activation.
Gerhard E Strittmatter, Jennifer Sand, Marlies Sauter, Michael Seyffert, Robin Steigerwald

J Invest Dermatol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses.
Sonia T Wennier, Kay Brinkmann, Charlotte Steinhäußer, Nicole Mayländer, Claudia Mnich, Robin Steigerwald

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells.
Stefanie J Mandl, Ryan B Rountree, Katie Dalpozzo, Lisa Do, John R Lombardo, Robin Steigerwald

Cancer Immunol Immunother· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.
Karen Baur, Kay Brinkmann, Marc Schweneker, Juliane Pätzold, Christine Meisinger-Henschel, Robin Steigerwald

J Virol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells.
Maria-Angeles Gonzalez-Carmona, Sabine Schüssler, Matthias Serwe, Michael Alt, János Ludwig, Robin Steigerwald

J Hepatol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requirements for adeno-associated virus-derived non-viral vectors to achieve stable and site-specific integration of plasmid DNA in liver carcinoma cells.
Robin Steigerwald, Christian Rabe, Volker Schmitz, Ingo G Schmidt-Wolf, Michael Alt

Digestion· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis